Skip to search formSkip to main contentSkip to account menu

JMR 132

Known as: JMR-132, JMR132 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Project of Monitory on the surveillance of the Pregnant Woman in Population of the General Hospital of Ecatepec JMR
2016
2016
Impact of Axis of GHRH and GHRH Receptor on Cell Viability and Apoptosis of the Placental Choriocarcinoma Cell Line.
Although GHRH and GHRH-R are recognized as key factors in placental development, little is known about the mechanism(s) of the… 
2014
2014
Name of Student: Praveena Manogaran Title of Presentation: Cortico-spinal Tract Integrity Measured Using Transcranial Magnetic Stimulation and Magnetic Resonance Imaging in Neuromyelitis Optica and…
Background: Multiple sclerosis (MS) is a neurological disease affecting mainly the myelin sheath. Neuromyelitis optica (NMO) is a… 
2013
2013
Hormone-ReleasingHormone andAntagonists of Luteinizing Hormone-ReleasingHormone in Shrinking Experimental Benign ProstaticHyperplasia
Ferenc G. Rick,* Andrew V. Schally, Norman L. Block, Andrew Abi-Chaker, Awtar Krishan, and Luca Szalontay Veterans AffairsMedical… 
2012
2012
Prostate cancer: GHRH antagonists could be effective in CRPC treatment
Researchers from Miami, Florida, propose a new therapeutic strategy for castration-resistant prostate cancer (CRPC) in their… 
2009
2009
Combination of a novel growth hormone releasing hormone Antagonist JMR 132 and Tamoxifen enhances the inhibitory effects on growth of ZR 75 and T47D estrogen dependent human breast cancer cells in…
Background: Tamoxifen is the oldest selective estrogen receptor modulator (SERM) developed to antagonize the estrogen receptor… 
2008
2008
Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist.
GHRH antagonists have been shown to inhibit growth of various human cancer cell lines xenografted into nude mice including… 
2008
2008
effects of growth hormone - releasing hormone antagonist JMR-132
2005
2005
Overexpression of Des(1–3) Insulin-Like Growth Factor 1 in the Mammary Glands of Transgenic Mice Delays the Loss of Milk Production with Prolonged Lactation1
Abstract During prolonged lactation, the mammary gland gradually loses the capacity to produce milk. In agricultural species… 
1988
1988
Tillard jmr. O bispo de roma. Sao paulo, ed loyola, 1985, 218 p
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)